• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Gilead’s Kite bags option to buy gamma delta startup Gadeta

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 19, 2018 at 11:22: AM
via Gilead’s Kite Pharma has snagged an option to buy gamma delta T-cell receptor (TCR) startup Gadeta. The deal sees Kite take a stake in Gadeta and commit to milestones tied to the progress of oncology candidates.

article source
 




Top Bottom
Back
Quote